Intelligent Bio Solutions Stock Analysis
| INBS Stock | USD 4.89 0.13 2.73% |
IPO Date 23rd of December 2020 | 200 Day MA 12.4317 | 50 Day MA 8.4818 | Beta 4.515 |
At this time, Intelligent Bio's Net Debt To EBITDA is comparatively stable compared to the past year. Debt To Equity is likely to gain to 0.09 in 2026, whereas Net Debt is likely to drop (697.5 K) in 2026. Intelligent Bio's financial risk is the risk to Intelligent Bio stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.0393 | Current Value 0.0373 | Quarterly Volatility 0.96610941 |
Intelligent Bio Solutions is undervalued with Real Value of 6.52 and Target Price of 12.0. The main objective of Intelligent Bio stock analysis is to determine its intrinsic value, which is an estimate of what Intelligent Bio Solutions is worth, separate from its market price. There are two main types of Intelligent Bio's stock analysis: fundamental analysis and technical analysis.
The Intelligent Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Intelligent Bio is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Intelligent Stock trading window is adjusted to America/New York timezone.
Intelligent | Build AI portfolio with Intelligent Stock |
Intelligent Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Intelligent Bio Solutions recorded a loss per share of 14.45. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 16th of December 2025. GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Intelligent Bio operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Intelligent Bio Solutions call Harry Simeonidis at 646 828 8258 or check out https://ibs.inc.Intelligent Bio Solutions Investment Alerts
| Intelligent Bio is way too risky over 90 days horizon | |
| Intelligent Bio appears to be risky and price may revert if volatility continues | |
| Intelligent Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 3.05 M. Net Loss for the year was (10.6 M) with profit before overhead, payroll, taxes, and interest of 1.65 M. | |
| Intelligent Bio Solutions currently holds about 8.28 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56. | |
| Latest headline from seekingalpha.com: Intelligent Bio Solutions GAAP EPS of -2.82, revenue of 0.89M |
Intelligent Largest EPS Surprises
Earnings surprises can significantly impact Intelligent Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-09 | 2022-09-30 | -0.1 | -0.08 | 0.02 | 20 | ||
2025-11-12 | 2025-09-30 | -0.27 | -0.35 | -0.08 | 29 | ||
2024-11-07 | 2024-09-30 | -0.53 | -0.7 | -0.17 | 32 |
Intelligent Bio Environmental, Social, and Governance (ESG) Scores
Intelligent Bio's ESG score is a quantitative measure that evaluates Intelligent Bio's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Intelligent Bio's operations that may have significant financial implications and affect Intelligent Bio's stock price as well as guide investors towards more socially responsible investments.
Intelligent Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2025-03-31 | 0.0 | Sbi Securities Co Ltd | 2025-06-30 | 0.0 | Two Sigma Securities, Llc | 2025-03-31 | 0.0 | Alyeska Investment Group, L.p. | 2025-06-30 | 613.9 K | Altium Capital Management, Lp | 2025-03-31 | 149.3 K | Geode Capital Management, Llc | 2025-06-30 | 51.5 K | Vanguard Group Inc | 2025-06-30 | 15.5 K | Goldman Sachs Group Inc | 2025-06-30 | 12.8 K | Renaissance Technologies Corp | 2025-06-30 | 10.9 K | Nbc Securities Inc | 2025-06-30 | 2.4 K | Ubs Group Ag | 2025-06-30 | 300 |
Intelligent Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.63 M.Intelligent Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.13) | (2.24) | |
| Return On Capital Employed | (4.22) | (4.01) | |
| Return On Assets | (1.15) | (1.21) | |
| Return On Equity | (4.06) | (3.85) |
Management Efficiency
Intelligent Bio Solutions has return on total asset (ROA) of (0.5117) % which means that it has lost $0.5117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.502) %, meaning that it created substantial loss on money invested by shareholders. Intelligent Bio's management efficiency ratios could be used to measure how well Intelligent Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.24 in 2026. Return On Capital Employed is likely to gain to -4.01 in 2026. At this time, Intelligent Bio's Non Currrent Assets Other are comparatively stable compared to the past year. Other Assets is likely to gain to about 1.3 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 3.4 M in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.48 | 0.96 | |
| Tangible Book Value Per Share | (0.17) | (0.16) | |
| Enterprise Value Over EBITDA | (0.13) | (0.14) | |
| Price Book Value Ratio | 0.75 | 0.79 | |
| Enterprise Value Multiple | (0.13) | (0.14) | |
| Price Fair Value | 0.75 | 0.79 | |
| Enterprise Value | 2 M | 1.9 M |
Intelligent Bio's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Technical Drivers
As of the 20th of February, Intelligent Bio retains the Market Risk Adjusted Performance of (0.44), downside deviation of 8.32, and Risk Adjusted Performance of 0.0328. Intelligent Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Intelligent Bio Solutions information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Intelligent Bio is priced fairly, providing market reflects its last-minute price of 4.89 per share. Given that Intelligent Bio Solutions has jensen alpha of 0.639, we strongly advise you to confirm Intelligent Bio Solutions's regular market performance to make sure the company can sustain itself at a future point.Intelligent Bio Solutions Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Simple Moving Average indicator is calculated by adding the closing price of Intelligent Bio for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Intelligent Bio Solutions short-term fluctuations and highlight longer-term trends or cycles.
Intelligent Bio Solutions Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Intelligent Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Intelligent Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Intelligent Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sakiris Spiro Kevin over a year ago Insider Trading | ||
Sakiris Spiro Kevin over a year ago Disposition of 9394 shares by Sakiris Spiro Kevin of Intelligent Bio subject to Rule 16b-3 | ||
Life Science Biosensor Diagnostics Pty Ltd over a year ago Sale by Life Science Biosensor Diagnostics Pty Ltd of 576028 shares of Intelligent Bio | ||
Towers Christopher over a year ago Purchase by Towers Christopher of 9090 shares of Intelligent Bio | ||
Sakiris Spiro Kevin over a year ago Intelligent Bio exotic insider transaction detected | ||
Sakiris Spiro Kevin over a year ago Intelligent Bio exotic insider transaction detected |
Intelligent Bio Outstanding Bonds
Intelligent Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Intelligent Bio Solutions uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Intelligent bonds can be classified according to their maturity, which is the date when Intelligent Bio Solutions has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| GE GLOBAL INS Corp BondUS36158FAD24 | View | |
| GE GLOBAL INS Corp BondUS36158FAA84 | View |
Intelligent Bio Predictive Daily Indicators
Intelligent Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Intelligent Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Intelligent Bio Forecast Models
Intelligent Bio's time-series forecasting models are one of many Intelligent Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Intelligent Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Intelligent Bio Bond Ratings
Intelligent Bio Solutions financial ratings play a critical role in determining how much Intelligent Bio have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Intelligent Bio's borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (3.49) | Unlikely Manipulator | View |
Intelligent Bio Solutions Debt to Cash Allocation
Many companies such as Intelligent Bio, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Intelligent Bio Solutions currently holds 281.81 K in liabilities. Intelligent Bio Solutions has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Intelligent Bio's use of debt, we should always consider it together with its cash and equity.Intelligent Bio Total Assets Over Time
Intelligent Bio Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Intelligent Bio uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Intelligent Bio Debt Ratio | 3.73 |
Intelligent Bio Corporate Bonds Issued
Intelligent Short Long Term Debt Total
Short Long Term Debt Total |
|
About Intelligent Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Intelligent Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intelligent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Intelligent Bio. By using and applying Intelligent Stock analysis, traders can create a robust methodology for identifying Intelligent entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (3.12) | (3.27) | |
| Operating Profit Margin | (3.14) | (3.30) | |
| Net Loss | (3.12) | (3.27) | |
| Gross Profit Margin | 0.37 | 0.30 |
Current Intelligent Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Intelligent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Intelligent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 12.0 | Strong Buy | 1 | Odds |
Most Intelligent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Intelligent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Intelligent Bio Solutions, talking to its executives and customers, or listening to Intelligent conference calls.
Intelligent Stock Analysis Indicators
Intelligent Bio Solutions stock analysis indicators help investors evaluate how Intelligent Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Intelligent Bio shares will generate the highest return on investment. By understating and applying Intelligent Bio stock analysis, traders can identify Intelligent Bio position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 6.3 M | |
| Common Stock Shares Outstanding | 527.4 K | |
| Total Stockholder Equity | 3 M | |
| Total Cashflows From Investing Activities | -231.8 K | |
| Property Plant And Equipment Net | 320.8 K | |
| Cash And Short Term Investments | 1 M | |
| Cash | 1 M | |
| Accounts Payable | 897.3 K | |
| Net Debt | -738.1 K | |
| 50 Day M A | 8.4818 | |
| Total Current Liabilities | 5.4 M | |
| Other Operating Expenses | 13.7 M | |
| Non Current Assets Total | 4.1 M | |
| Stock Based Compensation | 238 K |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.